TGFBRAP1 antisense RNA 1 (TGFBRAP1-AS1)

TGFBRAP1 antisense RNA 1 (TGFBRAP1-AS1, AC012360.1) is a long noncoding RNA gene annotated based on its location antisense to the protein-coding TGFBRAP1 gene[2]. There is currently no published experimental evidence validating TGFBRAP1-AS1 as a functional biomolecule; no data exist regarding its role as a therapeutic target, mechanism, biological processes, disease links, or drug interactions. This distinguishes it from its protein-coding counterpart TGFBRAP1, which is well described as an adaptor in TGF-beta signaling[1][4]. The designation "AS1" reflects antisense RNA nomenclature, not a known receptor, enzyme, transporter, or other canonical therapeutic target class. Interpretation notes: - Is target: TGFBRAP1-AS1 is *not considered a therapeutic target* in the sense of a receptor, enzyme, transporter, or signaling protein; it is a noncoding RNA with no described therapeutic relevance as of current knowledge[2]. - Is incorrect: The query does *not describe a valid protein target/receptor* but rather refers to a noncoding RNA with unclear function, thus entry is considered "incorrect" by the conventions requested. Additional clarification: - Most indexed biomedical databases and publications document only the (protein-coding) *TGFBRAP1*, not TGFBRAP1-AS1, as a molecular target with disease relevance and drug interactions[1][4]. - If you intended to inquire about *TGFBRAP1* (Transforming growth factor beta receptor-associated protein 1), it is a bona fide adaptor protein in TGF-beta signaling and closely related to cancer drug resistance mechanisms[1][4].

Other names

TGFBRAP1-AS1AC012360.1

None reported